Lenvatinib (mesylate), CAS [[857890-39-2]]
Artikelnummer:
MCE-HY-10981A
| Artikelname: |
Lenvatinib (mesylate), CAS [[857890-39-2]] |
| Artikelnummer: |
MCE-HY-10981A |
| Hersteller Artikelnummer: |
HY-10981A |
| Alternativnummer: |
MCE-HY-10981A-100MG,MCE-HY-10981A-25MG,MCE-HY-10981A-50MG,MCE-HY-10981A-10MMX1ML,MCE-HY-10981A-500MG |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Biochemikalien |
| Alternative Synonym: |
E7080 (mesylate) |
| Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities[1][2]. |
| Molekulargewicht: |
522.96 |
| Reinheit: |
99.86 |
| CAS Nummer: |
[857890-39-2] |
| Formel: |
C22H23ClN4O7S |
| Target-Kategorie: |
c-Kit,FGFR,PDGFR,RET,VEGFR |
| Anwendungsbeschreibung: |
MCE Product type: Reference compound1 |
